Research ArticleResearch Article

Wnt5a Signaling — A New and Attractive Target for Specific Anticancer Therapy

Xiao-hong SHEN, Dong LI, Hong-yue LI and Qiang LI
Clinical Oncology and Cancer Research February 2010, 7 (1) 1-6; DOI: https://doi.org/10.1007/s11805-010-0001-6

References

  1. ↵
    1. Clevers H.
    Wnt/β-catenin signaling in development and disease. Cell 2006; 127: 469-480.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Nusse R.
    Wnt signaling in disease and development. Cell Res 2005; 15: 28-32.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Wong GT,
    2. Gavin BJ,
    3. McMahon AP.
    Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol 1994; 14: 6278-6286.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Olson DJ,
    2. Papkoff J.
    Regulated expression of Wnt family members during proliferation of C57mg mammary cells. Cell Growth Differ 1994; 5: 197-206.
    OpenUrlAbstract
  5. ↵
    1. Wodarz A,
    2. Nusse R.
    Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59-88.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Kuhl M,
    2. Sheldahl LC,
    3. Park M, et al.
    The Wnt/Ca2+ pathway: a new vertebrate wnt signaling pathway takes shape. Trends Genet 2000; 16: 279-283.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Bhanot P,
    2. Brink M,
    3. Samos CH, et al.
    A new member of the frizzled family from Drosophila functions as a wingless receptor. Nature 1996; 282: 225-230.
    OpenUrl
    1. Yang-Snyder J,
    2. Miller JR,
    3. Brown JD, et al.
    A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol 1996; 6: 1302-1306.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Itoh K,
    2. Krupnik VE,
    3. Sokol SY.
    Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 1998; 8: 591-594.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Kishida S,
    2. Yamamoto H,
    3. Hino S, et al.
    DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 1999; 19: 4414–4422.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Lee JS,
    2. Ishimoto A,
    3. Yanagawa S.
    Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem 1999; 274: 21464–21470.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Rubinfeld B,
    2. Albert I,
    3. Porfiri E, et al.
    Binding of GSK3-β to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272: 1023–1026.
    OpenUrlAbstract
  13. ↵
    1. Behrens J,
    2. von Kries JP,
    3. Kuhl M, et al.
    Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638–642.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Sakanaka C,
    2. Leong P,
    3. Xu L, et al.
    Casein kinase-1 epsilon in the wnt pathway: Regulation of beta-catenin function. Proc Natl Acad Sci 1999; 96: 12548–12552.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Hsu W,
    2. Zeng L,
    3. Costantini F.
    Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 1999; 274: 3439–3445.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Sheldahl LC,
    2. Slusarski DC,
    3. Pandur P, et al.
    Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell Biol 2003; 26: 769–777.
    OpenUrl
  17. ↵
    1. Wallingford JB,
    2. Habas R.
    The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development 2005; 132: 4421–4436.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Seifert JR,
    2. Mlodzik M.
    Frizzled/PCP signaling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet 2007; 8: 126–138.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Jones C,
    2. Chen P.
    Planar cell polarity signaling in vertebrates. Bioessays 2007; 29: 120–132.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Oishi I,
    2. Suzuki H,
    3. Onishi N, et al.
    The receptor tyrosine kinase Ror2 is involved in noncanonical Wnt5a/JNK signaling pathway. Genes Cells 2003; 8: 645–654.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Schambony A,
    2. Wedlich D.
    Wnt-5a/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev Cell 2007; 5: 779–792.
    OpenUrl
  22. ↵
    1. Mikels AJ,
    2. Nusse R.
    Purified Wnt5a protein activates or inhibits b-catenin-TCF signaling depending on receptor context. PLoS Biol 2006; 4: 570–582.
    OpenUrlCrossRefWeb of Science
  23. ↵
    1. Nateri AS,
    2. Spencer-Dene B,
    3. Behrens A.
    Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 2005; 437: 281–285.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. He X,
    2. Saint-Jeannet JP,
    3. Wang Y, et al.
    A member of the frizzled protein family mediating axis induction by Wnt 5a. Science 1997; 275: 1652–1654.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Iozzo RV,
    2. Eichstetter I,
    3. Danielson KG.
    Aberrant expression of the growth factor Wnt-5a in human malignancy 1995; l16: 3299–3306.
  26. ↵
    1. Bittner M,
    2. Meltzer P,
    3. Chen Y, et al.
    Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406: 536–540.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Weeraratna AT,
    2. Jiang Y,
    3. Hostetter G, et al.
    Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1: 279–288.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. O’Connell MP,
    2. French AD,
    3. Leotlela PD, et al.
    Assaying Wnt5a-mediated invasion in melanoma cells. Methods Mol Biol 2008; 468: 243-53.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Bachmann IM,
    2. Straume O,
    3. Puntervoll HE, et al.
    Importance of P-cadherin, beta-catenin, and Wnt-5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11 (24 Pt 1).
  30. ↵
    1. Kurayoshi M,
    2. Oue N,
    3. Yamamoto H, et al.
    Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66:10439–10448.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Liu XH,
    2. Zhou HB,
    3. Ma HH, et al.
    Expression of Wnt5a, β-catenin and E-cadherin in hepatocellular carcinoma and its clinical significance. Chin J Clin Exp Pathol 2007; 23: 400-403 (Chinese).
    OpenUrl
  32. ↵
    1. Ripka S,
    2. Konig A,
    3. Buchholz M, et al.
    WNT5A-target of CUTL1and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 2007; 6: 1178–1187.
    OpenUrl
  33. ↵
    1. Dejmek J,
    2. Dejmek A,
    3. Safholm A, et al.
    Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 2005; 65: 9142–9146.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Smith K,
    2. Bui TD,
    3. Poulsom R, et al.
    Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer 1999; 81: 496–5021.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Lejeune S,
    2. Hugnet EL,
    3. Hamby A, et al.
    Wnt-5a cloning, expression, and up·regulation in human primary breast cancers. Clin Cancer Res 1995; 1: 215-222.
    OpenUrlAbstract
  36. ↵
    1. Jönsson M,
    2. Dejmek J,
    3. Bendahl PO, et al.
    Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res 2002; 62: 409–416.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Kremenevskaja N,
    2. von Wasielewski R,
    3. Rao AS, et al.
    Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 2005; 24: 2144-2154.
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. Bui TD,
    2. Zhang L,
    3. Rees MC, et al.
    Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer 1997; 75: 1131–1136.
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    1. Blanc E,
    2. Goldschneider D,
    3. Douc-Rasy S, et al.
    Wnt-5a gene expression in malignant human neuroblasts. Cancer Lett 2005; 228: 117–123.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Liang H,
    2. Chen Q,
    3. Coles AH, et al.
    Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoetic tissue. Cancer Cell 2003; 4: 349–360.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Zeng ZY,
    2. Zhou YH,
    3. Zhang WL, et al.
    Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007; 38: 120–133.
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Jönsson M,
    2. Andersson T.
    Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J Cell Sci 2001; 114: 2043–2053.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Tulac S,
    2. Nayak NR,
    3. Kao LC, et al.
    Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 2003; 88: 3860-3866.
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Dejmek J,
    2. Dejmek A,
    3. Safholm A, et al.
    Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 2005; 65: 9142–9146.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Säfholm A,
    2. Leandersson K,
    3. Dejmek J, et al.
    A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breastepithelial cells. J Biol Chem 2006; 281: 2740–49.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Nishita M,
    2. Yoo SK,
    3. Nomachi A, et al.
    Flopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 2006; 175: 555–562.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Gregorieff A,
    2. Pinto D,
    3. Begthel H, et al.
    Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005; 129: 626–638.
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Schenk S,
    2. Quaranta V.
    Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 2003; 13: 366–375.
    OpenUrlCrossRefPubMedWeb of Science
  49. ↵
    1. Mareel M,
    2. Leroy A.
    Clinical, cellular and molecular aspects of cancer invasion. Physiol Rev 2003; 83: 337–376.
    OpenUrlCrossRefPubMedWeb of Science
  50. ↵
    1. Blumenthal A,
    2. Ehlers S,
    3. Lauber J, et al.
    The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006; 108: 965–973.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Pukrop T,
    2. Klemm F,
    3. Hagemann T, et al.
    Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 2006; 103: 5454-5459.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords